Recto, Rudita .
HRN: 14-79-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
08/04/2023
08/11/2023
ORAL
30ml Susp
TID
Fungal Like Lesion Oral Area
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes